Overview
Dr. Hartwig is a thoracic surgeon with a clinical focus in lung transplantation and robotic assisted minimally invasive thoracic surgery for the treatment of diseases of the chest. He serves as the Surgical Director of the Duke Lung Transplant Program and the Esophageal Center at Duke. Additionally, he directs the Surgical Office of Clinical Research, which manages the clinical research portfolio for the Department of Surgery. He also leads a successful program of clinical, basic and translational research in thoracic surgery and lung transplantation. He currently directs the Duke Ex Vivo Organ Laboratory (DEVOL), is the Chief of Lung Transplant Research, and is a faculty member at the Duke Clinical Research Institute (DCRI).
Dr. Hartwig has over 150 peer reviewed publications, received numerous awards, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He has also personally mentored over pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.
Current Duke Appointments & Affiliations
Recent Scholarly Works
Improving equity of access/transparency in organ allocation.
Journal article Curr Opin Pulm Med · July 1, 2026 PURPOSE OF REVIEW: Persistent inequities in lung transplant access arise from biologic constraints, geographic variation, and system-level practices that are not fully addressed by urgency-based allocation alone. The recent implementation of continuous dis ... Full text Link to item CiteCorrigendum to "Combined heart-lung organ allocation: A glitch in the system" [J Heart Lung Transplant. 44 (2025) 2032-2034].
Journal article J Heart Lung Transplant · July 2026 Full text Link to item CiteHRSA-Defined Allocation Out of Sequence in Lung Transplantation.
Journal article Ann Surg · June 18, 2026 Full text Link to item CiteRecent Grants
US National OCS Lung Thoracic Organ Perfusion (TOP) Registry
Clinical TrialPrincipal Investigator · Awarded by TransMedics · 2024 - 2034Ex Vivo Delivery of Viral-Mediated Gene Therapy for the Amelioration of Post-Transplant Rejection
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2026 - 2031Transmedics DENOVO Trial - Pro00119843
Clinical TrialPrincipal Investigator · Awarded by TransMedics, Inc. · 2026 - 2031View All Grants